DJ Abbott Laboratories Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ slipped 2.59% to $105.52 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.58% to 7,673.52 and Dow Jones Industrial Average falling 1.18% to 52,786.07.
This was the stock's third consecutive day of losses.
Abbott Laboratories closed 23.25% below its 52-week high of $137.49, which the company achieved on September 22nd.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 2.22% to $269.12, Pfizer Inc. $(PFE)$ fell 2.32% to $27.79, and Merck & Co. Inc. (MRK) fell 1.24% to $148.46.
Trading volume (10.8 M) eclipsed its 50-day average volume of 10.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.